Generex Biotechnology Corporation (GNBT) Buy Target 1.40 – Sell Target 2 $2.85

Generex Biotechnology Corporation, through its subsidiaries, primarily engages in the administration of formulations of large molecule drugs to the oral cavity using a hand-held aerosol applicator in Canada and the United States. It offers Generex Oral-lyn, an insulin formulation administered as a fine spray into the oral cavity. The company is also developing AE37, a synthetic peptide vaccine to stimulate a potent and specific immune response against tumors with low levels of expression of the HER-2/neu oncogene in patients with breast cancer and prostate cancer

Trade Setup

Buy Target 1.40Sell Target 1 $2.25
Trailing Stop 20%Sell Target 2 $2.85

X